Skip to main content

Table 2 Distribution of herpesviruses in leukemic patients (ALL or AML)

From: Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy

Viral infectionPatients
N = 95 (%)
Patients with AML
N = 43 (%)
Patients with ALL
N = 52 (%)
P
Single CMV21 (22.1)12 (27.9)9 (17.3)0.227
Single EBV3 (3.1)3 (5.8)0.248
Single HHV-65 (5.3)2 (4.6)3 (5.8)1.000
Single HHV-74 (4.2)4 (7.7)1.000
CMV + HHV-615 (15.8)5 (11.6)10 (19.2)0.401
CMV + HHV-75 (5.3)4 (9.3)1 (2)0.172
EBV + HHV-71(1.1)1 (2)1.000
CMV + HHV6 + HHV72(2.1)2 (4.6)0.202
CMV + EBV + HHV62(2.1)1 (2.3)1 (2)1.000
EBV + HHV6 + HHV71(1.1)1 (2.3)0.452
EBV + CMV + HHV71(1.1)1 (2)1.000
Negative for all35(36.8)16 (37.2)19 (36.5)1.000
Positive for 1 or more60(63.2)27 (62.8)33 (63.5)1.000
  1. The patients were divided into two main groups according to the type of leukemia: (1) patients with AML (N = 43) and (2) patients with ALL (N = 52). A p value of < 0.05 was considered to be statistically significant